BioCentury | Mar 23, 2018
Financial News

Amazentis raises CHF8.4M, begins two Phase II trials

...and existing investors. The company also said it began two pivotal Phase II trials of AMAZ-02...
...muscle power in healthy overweight patients ages 40 to 65 who have low exercise tolerance. AMAZ-02...
Items per page:
1 - 1 of 1